Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Volixibat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mirum Highlights LIVMARLI And Volixibat Data At Liver Meeting
    Mirum Highlights LIVMARLI And Volixibat Data At Liver Meeting

    07 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251107860621/en/Mirum-Pharmaceuticals-Showcases-Leadership-in-Liver-Disease-Innovation-With-Data-From-LIVMARLI-and-Volixibat-Clinical-Programs-at-AASLDs-The-Liver-Meeting

    BUSINESSWIRE
    07 Nov 2025
    Share Share
    Volixibat Data from Mirum's VANTAGE PBC Study Showcased at EASL
    Volixibat Data from Mirum's VANTAGE PBC Study Showcased at EASL

    09 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250509189818/en/Volixibat-Data-from-Mirums-VANTAGE-PBC-Study-Showcased-at-EASL

    BUSINESSWIRE
    09 May 2025
    Share Share
    Mirum Pharma to Showcase Livmarli & Volixibat Data at AASLD
    Mirum Pharma to Showcase Livmarli & Volixibat Data at AASLD

    14 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241114053418/en

    BUSINESSWIRE
    14 Nov 2024
    Share Share
    Mirum’s Volixibat Achieves Positive Interim Analyses In VANTAGE PBC
    Mirum’s Volixibat Achieves Positive Interim Analyses In VANTAGE PBC

    17 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240617178174/en

    BUSINESSWIRE
    17 Jun 2024
    Share Share
    Mirum To Host Call On Volixibat VANTAGE VISTAS Interim Analysis
    Mirum To Host Call On Volixibat VANTAGE VISTAS Interim Analysis

    16 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240616032628/en

    BUSINESSWIRE
    16 Jun 2024
    Share Share
    Mirum Pharma to Showcase Analyses From Its Rare Liver Disease Programs at ILC
    Mirum Pharma to Showcase Analyses From Its Rare Liver Disease Programs at ILC

    16 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210616005316/en/Mirum-Pharmaceuticals-to-Showcase-Analyses-From-Its-Rare-Liver-Disease-Programs-at-The-International-Liver-Congress-2021

    BUSINESSWIRE
    16 Jun 2021
    Share Share